Connect with us

Cannabis News

Forbes Russia: Curaleaf Chairman Is The First Billionaire In The Cannabis Industry

Angie Nelson




Boris Jordan, the chairman, Curaleaf, is worth 1.1 billion dollars. According to Forbes Russia, Jordan stands out as the only billionaire so far for those who has ventured in the cannabis industry. He has a 31% stake in Curaleaf Company.

Curaleaf is located in Massachusetts and it deals exclusively in growing and processing of its own Marijuana. The cannabis market cap rates the company as the sixth most valued company in hemp production globally. The company runs 48 dispensaries across 12 states, and it deals with growing and processing marijuana as depicted on their official web page.

Jordan has invested heavily in some Russian and European-based companies through the Sputnik Group. Sputnik is a group of companies situated in Russia and some European states that was founded in 1998. Boris Jordan is also the founder of Measure 8 Ventures , which is another firm that deals with processing marijuana. Besides, he is also the chairman of one of the largest Russian Insurance company, Renaissance Insurance.

Jordan informed Benzinga that he visualizes Curaleaf as the lead firm in cannabis industry.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Follow Times of CBD News

popular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide is the most active daily cannabis news publication online inviting all readers to come for the headlines and stay for the insights. The primary focus is on curating latest CBD news updates, marijuana market movements and researched hemp-based product user guides. While everything is here for educational, informational purposes only, quality is always the priority and fact checking sources with industry-leading accuracy in reporting is at the top of the list of this emerging, innovative industry.

Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.

Got news? Email us [email protected]

Trending Cannabis News